No Data
FDA Solicits Public Comments On Use Of Cannabis-derived Products In Veterinary Medicine
Jefferies Maintains Tilray Brands(TLRY.US) With Buy Rating, Maintains Target Price $2.5
Peering Into Tilray Brands's Recent Short Interest
Tilray Investments in Vapes and Pre-Rolls Should Lift Weed Sales -- Market Talk
TD Cowen Maintains Tilray Brands(TLRY.US) With Buy Rating, Cuts Target Price to $1.5
A Quick Look at Today's Ratings for Tilray Brands(TLRY.US), With a Forecast Between $1.25 to $2